ArticleIDCases2026
Vision-threatening ocular toxoplasmosis involving the fovea diagnosed by intraocular fluid mNGS: A case report.
Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ocular toxoplasmosis is the most common cause of infectious posterior uveitis worldwide and may lead to irreversible visual impairment when the macula is involved. Definitive diagnosis remains challenging because clinical manifestations overlap with those of other infectious and inflammatory retinal disorders. We report a case of active ocular toxoplasmosis involving the fovea in an immunocompetent 44-year-old man presenting with progressive unilateral visual loss and central scotoma. Ophthalmic examination revealed keratic precipitates, mild vitritis, and a yellow-white inflammatory lesion involving the macular region. Fluorescein angiography demonstrated progressive hyperfluorescent staining, and optical coherence tomography showed a hyperreflective subfoveal lesion. Serological testing was positive for anti-Toxoplasma gondii IgM and IgG antibodies. Intraocular fluid analysis demonstrated positive anti-Toxoplasma IgG, while metagenomic next-generation sequencing (mNGS) directly identified Toxoplasma gondii DNA, providing molecular evidence supporting the diagnosis. The patient denied cat ownership or close feline exposure but reported occasional consumption of raw salmon. Treatment consisted of oral trimethoprim-sulfamethoxazole combined with methylprednisolone and two intravitreal injections of clindamycin plus dexamethasone. Significant regression of the retinal lesion was observed after treatment. This case highlights the diagnostic value of intraocular fluid mNGS in ocular toxoplasmosis and emphasizes the importance of considering ocular toxoplasmosis in patients presenting with posterior uveitis involving the macula, even in the absence of traditional epidemiological risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.